{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T06:16:51Z","timestamp":1792909011327,"version":"4.5.0"},"reference-count":203,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Cancer"],"DOI":"10.1038\/s41568-026-00985-1","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:01:16Z","timestamp":1791478876000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mapping the functional dark proteome in cancer"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7024-636X","authenticated-orcid":false,"given":"John R.","family":"Prensner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A.","family":"Freed-Pastor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer G.","family":"Abelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine J.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifat","family":"Merbl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3200-9344","authenticated-orcid":false,"given":"Yitzhak","family":"Pilpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0517-8804","authenticated-orcid":false,"given":"Ton N.","family":"Schumacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2445-670X","authenticated-orcid":false,"given":"Jonathan S.","family":"Weissman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9593-1980","authenticated-orcid":false,"given":"Sebastiaan","family":"van Heesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2848-2473","authenticated-orcid":false,"given":"Reuven","family":"Agami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"985_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s13040-017-0144-6","volume":"10","author":"N Perdig\u00e3o","year":"2017","unstructured":"Perdig\u00e3o, N., Rosa, A. C. & O\u2019Donoghue, S. I. The dark proteome database. BioData Min. 10, 24 (2017).","journal-title":"BioData Min."},{"key":"985_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/pmic.201800352","volume":"18","author":"VN Uversky","year":"2018","unstructured":"Uversky, V. N. Bringing darkness to light: intrinsic disorder as a means to dig into the dark proteome. Proteomics 18, e1800352 (2018).","journal-title":"Proteomics"},{"key":"985_CR3","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.tcb.2021.10.010","volume":"32","author":"BW Wright","year":"2022","unstructured":"Wright, B. W., Yi, Z., Weissman, J. S. & Chen, J. The dark proteome: translation from noncanonical open reading frames. Trends Cell Biol. 32, 243\u2013258 (2022).","journal-title":"Trends Cell Biol."},{"key":"985_CR4","doi-asserted-by":"publisher","first-page":"100719","DOI":"10.1016\/j.mcpro.2024.100719","volume":"23","author":"X Cao","year":"2024","unstructured":"Cao, X., Sun, S. & Xing, J. A massive proteogenomic screen identifies thousands of novel peptides from the human \u201cdark\u201d proteome. Mol. Cell. Proteom. 23, 100719 (2024).","journal-title":"Mol. Cell. Proteom."},{"key":"985_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/nar\/gkz734","volume":"48","author":"MW Orr","year":"2020","unstructured":"Orr, M. W., Mao, Y., Storz, G. & Qian, S.-B. Alternative ORFs and small ORFs: shedding light on the dark proteome. Nucleic Acids Res. 48, 1029\u20131042 (2020).","journal-title":"Nucleic Acids Res."},{"key":"985_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/pro.4708","volume":"32","author":"Z Posner","year":"2023","unstructured":"Posner, Z., Yannuzzi, I. & Prensner, J. R. Shining a light on the dark proteome: non-canonical open reading frames and their encoded miniproteins as a new frontier in cancer biology. Protein Sci. 32, e4708 (2023).","journal-title":"Protein Sci."},{"key":"985_CR7","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/d41586-025-00217-w","volume":"637","author":"E Callaway","year":"2025","unstructured":"Callaway, E. \u201cDark proteins\u201d hiding in our cells could hold clues to cancer and other diseases. Nature 637, 1038\u20131040 (2025).","journal-title":"Nature"},{"key":"985_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37547-0","volume":"14","author":"JG Abelin","year":"2023","unstructured":"Abelin, J. G. et al. Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues. Nat. Commun. 14, 1851 (2023).","journal-title":"Nat. Commun."},{"key":"985_CR9","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1038\/s41586-020-03054-1","volume":"590","author":"O Bartok","year":"2021","unstructured":"Bartok, O. et al. Anti-tumour immunity induces aberrant peptide presentation in melanoma. Nature 590, 332\u2013337 (2021).","journal-title":"Nature"},{"key":"985_CR10","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s43018-023-00548-5","volume":"4","author":"AI Kraemer","year":"2023","unstructured":"Kraemer, A. I. et al. The immunopeptidome landscape associated with T cell infiltration, inflammation and immune editing in lung cancer. Nat. Cancer 4, 608\u2013628 (2023).","journal-title":"Nat. Cancer"},{"key":"985_CR11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41587-021-01021-3","volume":"40","author":"T Ouspenskaia","year":"2022","unstructured":"Ouspenskaia, T. et al. Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer. Nat. Biotechnol. 40, 209\u2013217 (2022).","journal-title":"Nat. Biotechnol."},{"key":"985_CR12","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1038\/s41586-026-10459-x","volume":"654","author":"EW Deutsch","year":"2026","unstructured":"Deutsch, E. W. et al. Expanding the human proteome with microproteins and peptideins. Nature 654, 813\u2013825\u00a0(2026).","journal-title":"Nature"},{"key":"985_CR13","doi-asserted-by":"publisher","first-page":"D529","DOI":"10.1093\/nar\/gkaa853","volume":"49","author":"ME Berginski","year":"2021","unstructured":"Berginski, M. E. et al. The dark kinase knowledgebase: an online compendium of knowledge and experimental results of understudied kinases. Nucleic Acids Res. 49, D529\u2013D535 (2021).","journal-title":"Nucleic Acids Res."},{"key":"985_CR14","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1039\/D1MD00228G","volume":"13","author":"S M\u00fcller","year":"2022","unstructured":"M\u00fcller, S. et al. Target 2035 - update on the quest for a probe for every protein. RSC Med. Chem. 13, 13\u201321 (2022).","journal-title":"RSC Med. Chem."},{"key":"985_CR15","doi-asserted-by":"publisher","first-page":"158","DOI":"10.3389\/fgene.2018.00158","volume":"9","author":"AL Darling","year":"2018","unstructured":"Darling, A. L. & Uversky, V. N. Intrinsic disorder and posttranslational modifications: the darker side of the biological dark matter. Front. Genet. 9, 158 (2018).","journal-title":"Front. Genet."},{"key":"985_CR16","doi-asserted-by":"publisher","first-page":"9730","DOI":"10.1021\/jacs.6b06543","volume":"138","author":"A Bhowmick","year":"2016","unstructured":"Bhowmick, A. et al. Finding our way in the dark proteome. J. Am. Chem. Soc. 138, 9730\u20139742 (2016).","journal-title":"J. Am. Chem. Soc."},{"key":"985_CR17","doi-asserted-by":"publisher","first-page":"15898","DOI":"10.1073\/pnas.1508380112","volume":"112","author":"N Perdig\u00e3o","year":"2015","unstructured":"Perdig\u00e3o, N. et al. Unexpected features of the dark proteome. Proc. Natl Acad. Sci. USA 112, 15898\u201315903 (2015).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"985_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.3390\/vaccines14010104","volume":"14","author":"FX Rwandamuriye","year":"2026","unstructured":"Rwandamuriye, F. X., Redwood, A. J., Creaney, J. & Robinson, B. W. S. Hidden targets in cancer immunotherapy: the potential of \u201cdark matter\u201d neoantigens. Vaccines 14, 104 (2026).","journal-title":"Vaccines"},{"key":"985_CR19","unstructured":"Cancer Grand Challenges. The Dark Proteome https:\/\/www.cancergrandchallenges.org\/the-dark-proteome (2025)."},{"key":"985_CR20","doi-asserted-by":"publisher","first-page":"gkag234","DOI":"10.1093\/nar\/gkag234","volume":"54","author":"S Chothani","year":"2026","unstructured":"Chothani, S. et al. An expanded reference catalog of translated open reading frames for biomedical research. Nucleic Acids Res. 54, gkag234 (2026).","journal-title":"Nucleic Acids Res."},{"key":"985_CR21","doi-asserted-by":"publisher","first-page":"100631","DOI":"10.1016\/j.mcpro.2023.100631","volume":"22","author":"JR Prensner","year":"2023","unstructured":"Prensner, J. R. et al. What can Ribo-seq, immunopeptidomics, and proteomics tell us about the noncanonical proteome? Mol. Cell. Proteom. 22, 100631 (2023).","journal-title":"Mol. Cell. Proteom."},{"key":"985_CR22","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1016\/j.molcel.2023.01.023","volume":"83","author":"C-L Sandmann","year":"2023","unstructured":"Sandmann, C.-L. et al. Evolutionary origins and interactomes of human, young microproteins and small peptides translated from short open reading frames. Mol. Cell 83, 994\u20131011.e18 (2023).","journal-title":"Mol. Cell"},{"key":"985_CR23","doi-asserted-by":"publisher","first-page":"111808","DOI":"10.1016\/j.celrep.2022.111808","volume":"41","author":"N Vakirlis","year":"2022","unstructured":"Vakirlis, N., Vance, Z., Duggan, K. M. & McLysaght, A. De novo birth of functional microproteins in the human lineage. Cell Rep. 41, 111808 (2022).","journal-title":"Cell Rep."},{"key":"985_CR24","doi-asserted-by":"publisher","first-page":"111940","DOI":"10.1016\/j.yexcr.2020.111940","volume":"391","author":"J Ruiz-Orera","year":"2020","unstructured":"Ruiz-Orera, J., Villanueva-Ca\u00f1as, J. L. & Alb\u00e0, M. M. Evolution of new proteins from translated sORFs in long non-coding RNAs. Exp. Cell Res. 391, 111940 (2020).","journal-title":"Exp. Cell Res."},{"key":"985_CR25","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s44161-024-00544-7","volume":"3","author":"J Ruiz-Orera","year":"2024","unstructured":"Ruiz-Orera, J. et al. Evolution of translational control and the emergence of genes and open reading frames in human and non-human primate hearts. Nat. Cardiovasc. Res. 3, 1217\u20131235 (2024).","journal-title":"Nat. Cardiovasc. Res."},{"key":"985_CR26","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1126\/science.273.5275.595","volume":"273","author":"L Holm","year":"1996","unstructured":"Holm, L. & Sander, C. Mapping the protein universe. Science 273, 595\u2013603 (1996).","journal-title":"Science"},{"key":"985_CR27","doi-asserted-by":"publisher","first-page":"eadq4946","DOI":"10.1126\/science.adq4946","volume":"386","author":"AM Lau","year":"2024","unstructured":"Lau, A. M. et al. Exploring structural diversity across the protein universe with The Encyclopedia of Domains. Science 386, eadq4946 (2024).","journal-title":"Science"},{"key":"985_CR28","doi-asserted-by":"publisher","first-page":"i275","DOI":"10.1093\/bioinformatics\/btr209","volume":"27","author":"MF Lin","year":"2011","unstructured":"Lin, M. F., Jungreis, I. & Kellis, M. PhyloCSF: a comparative genomics method to distinguish protein coding and non-coding regions. Bioinformatics 27, i275\u2013i282 (2011).","journal-title":"Bioinformatics"},{"key":"985_CR29","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589 (2021).","journal-title":"Nature"},{"key":"985_CR30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","volume":"25","author":"R Arafeh","year":"2025","unstructured":"Arafeh, R., Shibue, T., Dempster, J. M., Hahn, W. C. & Vazquez, F. The present and future of the cancer dependency map. Nat. Rev. Cancer 25, 59\u201373 (2025).","journal-title":"Nat. Rev. Cancer"},{"key":"985_CR31","unstructured":"UniProt Consortium. UniProt: the Universal Protein Knowledgebase in 2025. Nucleic Acids Res. 53, D609\u2013D617 (2025)."},{"key":"985_CR32","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1038\/s41586-022-04499-2","volume":"603","author":"A Pataskar","year":"2022","unstructured":"Pataskar, A. et al. Tryptophan depletion results in tryptophan-to-phenylalanine substitutants. Nature 603, 721\u2013727 (2022).","journal-title":"Nature"},{"key":"985_CR33","doi-asserted-by":"publisher","first-page":"13964","DOI":"10.1093\/nar\/gkae1110","volume":"52","author":"A Kochavi","year":"2024","unstructured":"Kochavi, A. et al. Chemotherapeutic agents and leucine deprivation induce codon-biased aberrant protein production in cancer. Nucleic Acids Res. 52, 13964\u201313979 (2024).","journal-title":"Nucleic Acids Res."},{"key":"985_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63405-2","volume":"16","author":"A Kowar","year":"2025","unstructured":"Kowar, A. et al. Upstream open reading frame translation enhances immunogenic peptide presentation in mitotically arrested cancer cells. Nat. Commun. 16, 8008 (2025).","journal-title":"Nat. Commun."},{"key":"985_CR35","doi-asserted-by":"publisher","first-page":"D966","DOI":"10.1093\/nar\/gkae1078","volume":"53","author":"JM Mudge","year":"2025","unstructured":"Mudge, J. M. et al. GENCODE 2025: reference gene annotation for human and mouse. Nucleic Acids Res. 53, D966\u2013D975 (2025).","journal-title":"Nucleic Acids Res."},{"key":"985_CR36","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1038\/nprot.2006.359","volume":"1","author":"J Blonder","year":"2006","unstructured":"Blonder, J., Chan, K. C., Issaq, H. J. & Veenstra, T. D. Identification of membrane proteins from mammalian cell\/tissue using methanol-facilitated solubilization and tryptic digestion coupled with 2D-LC-MS\/MS. Nat. Protoc. 1, 2784\u20132790 (2006).","journal-title":"Nat. Protoc."},{"key":"985_CR37","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1152\/physiolgenomics.00279.2006","volume":"30","author":"SP Mirza","year":"2007","unstructured":"Mirza, S. P., Halligan, B. D., Greene, A. S. & Olivier, M. Improved method for the analysis of membrane proteins by mass spectrometry. Physiol. Genom. 30, 89\u201394 (2007).","journal-title":"Physiol. Genom."},{"key":"985_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jprot.2016.03.016","volume":"149","author":"O Vit","year":"2016","unstructured":"Vit, O. et al. Large-scale identification of membrane proteins based on analysis of trypsin-protected transmembrane segments. J. Proteom. 149, 15\u201322 (2016).","journal-title":"J. Proteom."},{"key":"985_CR39","doi-asserted-by":"publisher","first-page":"100206","DOI":"10.1016\/j.mcpro.2022.100206","volume":"21","author":"P Kongpracha","year":"2022","unstructured":"Kongpracha, P. et al. Simple but efficacious enrichment of integral membrane proteins and their interactions for in-depth membrane proteomics. Mol. Cell. Proteom. 21, 100206 (2022).","journal-title":"Mol. Cell. Proteom."},{"key":"985_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3002409","volume":"21","author":"A Wacholder","year":"2023","unstructured":"Wacholder, A. & Carvunis, A.-R. Biological factors and statistical limitations prevent detection of most noncanonical proteins by mass spectrometry. PLoS Biol. 21, e3002409 (2023).","journal-title":"PLoS Biol."},{"key":"985_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-68002-x","volume":"17","author":"A Wacholder","year":"2026","unstructured":"Wacholder, A. et al. Community benchmarking and evaluation of human unannotated microprotein detection by mass spectrometry based proteomics. Nat. Commun. 17, 1241 (2026).","journal-title":"Nat. Commun."},{"key":"985_CR42","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14500-z","volume":"11","author":"N Vakirlis","year":"2020","unstructured":"Vakirlis, N. et al. De novo emergence of adaptive membrane proteins from thymine-rich genomic sequences. Nat. Commun. 11, 781 (2020).","journal-title":"Nat. Commun."},{"key":"985_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-62647-4","volume":"16","author":"IE Shapiro","year":"2025","unstructured":"Shapiro, I. E., Huber, F., Michaux, J. & Bassani-Sternberg, M. Sensitive neoantigen discovery by real-time mutanome-guided immunopeptidomics. Nat. Commun. 16, 7269 (2025).","journal-title":"Nat. Commun."},{"key":"985_CR44","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41587-023-01945-y","volume":"42","author":"HR Gurung","year":"2024","unstructured":"Gurung, H. R. et al. Systematic discovery of neoepitope-HLA pairs for neoantigens shared among patients and tumor types. Nat. Biotechnol. 42, 1107\u20131117 (2024).","journal-title":"Nat. Biotechnol."},{"key":"985_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16588-9","volume":"11","author":"LE Stopfer","year":"2020","unstructured":"Stopfer, L. E., Mesfin, J. M., Joughin, B. A., Lauffenburger, D. A. & White, F. M. Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4\/6 inhibition. Nat. Commun. 11, 2760 (2020).","journal-title":"Nat. Commun."},{"key":"985_CR46","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20250444","volume":"222","author":"O Leddy","year":"2025","unstructured":"Leddy, O., Yuki, Y., Carrington, M., Bryson, B. D. & White, F. M. Targeting infection-specific peptides in immunopeptidomics studies for vaccine target discovery. J. Exp. Med. 222, e20250444 (2025).","journal-title":"J. Exp. Med."},{"key":"985_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-49212-1","volume":"15","author":"K Siew","year":"2024","unstructured":"Siew, K. et al. Cosmic kidney disease: an integrated pan-omic, physiological and morphological study into spaceflight-induced renal dysfunction. Nat. Commun. 15, 4923 (2024).","journal-title":"Nat. Commun."},{"key":"985_CR48","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1016\/j.jmb.2019.01.044","volume":"431","author":"S Kaur","year":"2019","unstructured":"Kaur, S., Baldi, B., Vuong, J. & O\u2019Donoghue, S. I. Visualization and analysis of epiproteome dynamics. J. Mol. Biol. 431, 1519\u20131539 (2019).","journal-title":"J. Mol. Biol."},{"key":"985_CR49","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/s41587-022-01464-2","volume":"41","author":"A Kacen","year":"2023","unstructured":"Kacen, A. et al. Post-translational modifications reshape the antigenic landscape of the MHC I immunopeptidome in tumors. Nat. Biotechnol. 41, 239\u2013251 (2023).","journal-title":"Nat. Biotechnol."},{"key":"985_CR50","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.4279","author":"H Wolf-Levy","year":"2018","unstructured":"Wolf-Levy, H. et al. Revealing the cellular degradome by mass spectrometry analysis of proteasome-cleaved peptides. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/nbt.4279 (2018).","journal-title":"Nat. Biotechnol."},{"key":"985_CR51","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.cell.2019.05.010","volume":"178","author":"S van Heesch","year":"2019","unstructured":"van Heesch, S. et al. The translational landscape of the human heart. Cell 178, 242\u2013260.e29 (2019).","journal-title":"Cell"},{"key":"985_CR52","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14968-9","volume":"11","author":"C Chong","year":"2020","unstructured":"Chong, C. et al. Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes. Nat. Commun. 11, 1293 (2020).","journal-title":"Nat. Commun."},{"key":"985_CR53","doi-asserted-by":"publisher","first-page":"eadk3487","DOI":"10.1126\/science.adk3487","volume":"388","author":"ZA Ely","year":"2025","unstructured":"Ely, Z. A. et al. Pancreatic cancer-restricted cryptic antigens are targets for T cell recognition. Science 388, eadk3487 (2025).","journal-title":"Science"},{"key":"985_CR54","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1038\/s41587-022-01369-0","volume":"40","author":"JM Mudge","year":"2022","unstructured":"Mudge, J. M. et al. Standardized annotation of translated open reading frames. Nat. Biotechnol. 40, 994\u2013999 (2022).","journal-title":"Nat. Biotechnol."},{"key":"985_CR55","doi-asserted-by":"publisher","first-page":"2885","DOI":"10.1016\/j.molcel.2022.06.023","volume":"82","author":"SP Chothani","year":"2022","unstructured":"Chothani, S. P. et al. A high-resolution map of human RNA translation. Mol. Cell 82, 2885\u20132899.e8 (2022).","journal-title":"Mol. Cell"},{"key":"985_CR56","doi-asserted-by":"publisher","first-page":"bbae268","DOI":"10.1093\/bib\/bbae268","volume":"25","author":"G Tong","year":"2024","unstructured":"Tong, G., Hah, N. & Martinez, T. F. Comparison of software packages for detecting unannotated translated small open reading frames by Ribo-seq. Brief. Bioinform. 25, bbae268 (2024).","journal-title":"Brief. Bioinform."},{"key":"985_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-56543-0","volume":"16","author":"J Clauwaert","year":"2025","unstructured":"Clauwaert, J. et al. Deep learning to decode sites of RNA translation in normal and cancerous tissues. Nat. Commun. 16, 1275 (2025).","journal-title":"Nat. Commun."},{"key":"985_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-981-10-5203-3_1","volume":"1008","author":"J Jarroux","year":"2017","unstructured":"Jarroux, J., Morillon, A. & Pinskaya, M. History, discovery, and classification of lncRNAs. Adv. Exp. Med. Biol. 1008, 1\u201346 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"985_CR59","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee, R. C., Feinbaum, R. L. & Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843\u2013854 (1993).","journal-title":"Cell"},{"key":"985_CR60","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/nrg1379","volume":"5","author":"L He","year":"2004","unstructured":"He, L. & Hannon, G. J. MicroRNAs: small RNAs with a big role in gene regulation. Nat. Rev. Genet. 5, 522\u2013531 (2004).","journal-title":"Nat. Rev. Genet."},{"key":"985_CR61","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/nature07672","volume":"458","author":"M Guttman","year":"2009","unstructured":"Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223\u2013227 (2009).","journal-title":"Nature"},{"key":"985_CR62","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.cell.2013.06.009","volume":"154","author":"M Guttman","year":"2013","unstructured":"Guttman, M., Russell, P., Ingolia, N. T., Weissman, J. S. & Lander, E. S. Ribosome profiling provides evidence that large noncoding RNAs do not encode proteins. Cell 154, 240\u2013251 (2013).","journal-title":"Cell"},{"key":"985_CR63","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.cell.2011.10.002","volume":"147","author":"NT Ingolia","year":"2011","unstructured":"Ingolia, N. T., Lareau, L. F. & Weissman, J. S. Ribosome profiling of mouse embryonic stem cells reveals the complexity and dynamics of mammalian proteomes. Cell 147, 789\u2013802 (2011).","journal-title":"Cell"},{"key":"985_CR64","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1126\/science.1168978","volume":"324","author":"NT Ingolia","year":"2009","unstructured":"Ingolia, N. T., Ghaemmaghami, S., Newman, J. R. S. & Weissman, J. S. Genome-wide analysis in vivo of translation with nucleotide resolution using ribosome profiling. Science 324, 218\u2013223 (2009).","journal-title":"Science"},{"key":"985_CR65","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.celrep.2014.07.045","volume":"8","author":"NT Ingolia","year":"2014","unstructured":"Ingolia, N. T. et al. Ribosome profiling reveals pervasive translation outside of annotated protein-coding genes. Cell Rep. 8, 1365\u20131379 (2014).","journal-title":"Cell Rep."},{"key":"985_CR66","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.08890","volume":"4","author":"Z Ji","year":"2015","unstructured":"Ji, Z., Song, R., Regev, A. & Struhl, K. Many lncRNAs, 5\u2019UTRs, and pseudogenes are translated and some are likely to express functional proteins. eLife 4, e08890 (2015).","journal-title":"eLife"},{"key":"985_CR67","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1021\/acs.jproteome.9b00599","volume":"19","author":"P Cloutier","year":"2020","unstructured":"Cloutier, P. et al. Upstream ORF-encoded ASDURF is a novel prefoldin-like subunit of the PAQosome. J. Proteome Res. 19, 18\u201327 (2020).","journal-title":"J. Proteome Res."},{"key":"985_CR68","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.molcel.2023.12.003","volume":"84","author":"DA Hofman","year":"2024","unstructured":"Hofman, D. A. et al. Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma. Mol. Cell 84, 261\u2013276.e18 (2024).","journal-title":"Mol. Cell"},{"key":"985_CR69","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cmet.2020.12.008","volume":"33","author":"N Huang","year":"2021","unstructured":"Huang, N. et al. An upstream open reading frame in phosphatase and tensin homolog encodes a circuit breaker of lactate metabolism. Cell Metab. 33, 128\u2013144.e9 (2021).","journal-title":"Cell Metab."},{"key":"985_CR70","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1093\/neuonc\/noad099","volume":"25","author":"N Huang","year":"2023","unstructured":"Huang, N. et al. Upstream open reading frame-encoded MP31 disrupts the mitochondrial quality control process and inhibits tumorigenesis in glioblastoma. Neuro Oncol. 25, 1947\u20131962 (2023).","journal-title":"Neuro Oncol."},{"key":"985_CR71","doi-asserted-by":"publisher","first-page":"eadk9524","DOI":"10.1126\/scitranslmed.adk9524","volume":"16","author":"F Li","year":"2024","unstructured":"Li, F. et al. A peptide encoded by upstream open reading frame of MYC binds to tropomyosin receptor kinase B and promotes glioblastoma growth in mice. Sci. Transl. Med. 16, eadk9524 (2024).","journal-title":"Sci. Transl. Med."},{"key":"985_CR72","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2018899118","volume":"118","author":"DR Jayaram","year":"2021","unstructured":"Jayaram, D. R. et al. Unraveling the hidden role of a uORF-encoded peptide as a kinase inhibitor of PKCs. Proc. Natl Acad. Sci. USA 118, e2018899118 (2021).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"985_CR73","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1038\/s41594-023-01117-1","volume":"30","author":"C Zheng","year":"2023","unstructured":"Zheng, C. et al. CRISPR-Cas9-based functional interrogation of unconventional translatome reveals human cancer dependency on cryptic non-canonical open reading frames. Nat. Struct. Mol. Biol. 30, 1878\u20131892 (2023).","journal-title":"Nat. Struct. Mol. Biol."},{"key":"985_CR74","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1038\/nature11661","volume":"493","author":"M Kretz","year":"2013","unstructured":"Kretz, M. et al. Control of somatic tissue differentiation by the long non-coding RNA TINCR. Nature 493, 231\u2013235 (2013).","journal-title":"Nature"},{"key":"985_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36713-8","volume":"14","author":"L Morgado-Palacin","year":"2023","unstructured":"Morgado-Palacin, L. et al. The TINCR ubiquitin-like microprotein is a tumor suppressor in squamous cell carcinoma. Nat. Commun. 14, 1328 (2023).","journal-title":"Nat. Commun."},{"key":"985_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34529-6","volume":"13","author":"O Boix","year":"2022","unstructured":"Boix, O. et al. pTINCR microprotein promotes epithelial differentiation and suppresses tumor growth through CDC42 SUMOylation and activation. Nat. Commun. 13, 6840 (2022).","journal-title":"Nat. Commun."},{"key":"985_CR77","doi-asserted-by":"publisher","first-page":"2759","DOI":"10.1016\/j.molcel.2025.05.033","volume":"85","author":"J Nah","year":"2025","unstructured":"Nah, J. et al. Microprotein SMIM26 drives oxidative metabolism via serine-responsive mitochondrial translation. Mol. Cell 85, 2759\u20132775.e12 (2025).","journal-title":"Mol. Cell"},{"key":"985_CR78","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202256282","volume":"24","author":"K Meng","year":"2023","unstructured":"Meng, K. et al. LINC00493-encoded microprotein SMIM26 exerts anti-metastatic activity in renal cell carcinoma. EMBO Rep. 24, e56282 (2023).","journal-title":"EMBO Rep."},{"key":"985_CR79","doi-asserted-by":"publisher","unstructured":"Valdivia-Francia, F. et al. In vivo single-cell CRISPR screening for microproteins identifies a critical ribosomal component. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.03.17.643322 (2025).","DOI":"10.1101\/2025.03.17.643322"},{"key":"985_CR80","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41392-025-02128-8","volume":"10","author":"K Meng","year":"2025","unstructured":"Meng, K. et al. The cryptic lncRNA-encoded microprotein TPM3P9 drives oncogenic RNA splicing and tumorigenesis. Signal Transduct. Target. Ther. 10, 43 (2025).","journal-title":"Signal Transduct. Target. Ther."},{"key":"985_CR81","doi-asserted-by":"publisher","first-page":"111884","DOI":"10.1016\/j.isci.2025.111884","volume":"28","author":"D Schlesinger","year":"2025","unstructured":"Schlesinger, D. et al. A large-scale sORF screen identifies putative microproteins involved in cancer cell fitness. iScience 28, 111884 (2025).","journal-title":"iScience"},{"key":"985_CR82","doi-asserted-by":"publisher","first-page":"eabj3671","DOI":"10.1126\/sciadv.abj3671","volume":"8","author":"P Bonaventura","year":"2022","unstructured":"Bonaventura, P. et al. Identification of shared tumor epitopes from endogenous retroviruses inducing high-avidity cytotoxic T cells for cancer immunotherapy. Sci. Adv. 8, eabj3671 (2022).","journal-title":"Sci. Adv."},{"key":"985_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1034\/j.1600-065X.2002.18805.x","volume":"188","author":"K-D Preuss","year":"2002","unstructured":"Preuss, K.-D., Zwick, C., Bormann, C., Neumann, F. & Pfreundschuh, M. Analysis of the B-cell repertoire against antigens expressed by human neoplasms. Immunol. Rev. 188, 43\u201350 (2002).","journal-title":"Immunol. Rev."},{"key":"985_CR84","doi-asserted-by":"publisher","first-page":"657187","DOI":"10.3389\/fonc.2021.657187","volume":"11","author":"V Weyerer","year":"2021","unstructured":"Weyerer, V. et al. Endogenous retroviral-K envelope is a novel tumor antigen and prognostic indicator of renal cell carcinoma. Front. Oncol. 11, 657187 (2021).","journal-title":"Front. Oncol."},{"key":"985_CR85","doi-asserted-by":"publisher","unstructured":"McKerrow, W. et al. LINE-1 ORF1p is a shared and immunogenic antigen in cancer. Preprint at bioRxiv https:\/\/doi.org\/10.1101\/2025.06.11.659092 (2025).","DOI":"10.1101\/2025.06.11.659092"},{"key":"985_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2025.08.002","author":"MF Grinwald","year":"2025","unstructured":"Grinwald, M. F., Saintilnord, W. N. & Wang, T. Unmasked: transposable elements as drivers and targets in cancer. Trends Genet. https:\/\/doi.org\/10.1016\/j.tig.2025.08.002 (2025).","journal-title":"Trends Genet."},{"key":"985_CR87","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature14308","volume":"522","author":"EJ Grow","year":"2015","unstructured":"Grow, E. J. et al. Intrinsic retroviral reactivation in human preimplantation embryos and pluripotent cells. Nature 522, 221\u2013225 (2015).","journal-title":"Nature"},{"key":"985_CR88","first-page":"230","volume":"Nature\u00a0650","author":"T Zhang","year":"2023","unstructured":"Zhang, T. et al. Uncovering the role of LINE-1 in the evolution of lung adenocarcinoma. Nature\u00a0650, 230\u2013241 (2026).","journal-title":"Nature"},{"key":"985_CR89","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-25-4773","author":"R Nagel","year":"2026","unstructured":"Nagel, R. et al. Arginine deprivation of ASS1-deficient cancers drives mistranslation and shared neoepitope production. Cancer Res. https:\/\/doi.org\/10.1158\/0008-5472.CAN-25-4773 (2026).","journal-title":"Cancer Res."},{"key":"985_CR90","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/s43018-020-0106-7","volume":"1","author":"R Keshet","year":"2020","unstructured":"Keshet, R. et al. Targeting purine synthesis in ASS1-expressing tumors enhances the response to immune checkpoint inhibitors. Nat. Cancer 1, 894\u2013908 (2020).","journal-title":"Nat. Cancer"},{"key":"985_CR91","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/s43018-023-00557-4","volume":"4","author":"A Javitt","year":"2023","unstructured":"Javitt, A. et al. The proteasome regulator PSME4 modulates proteasome activity and antigen diversity to abrogate antitumor immunity in NSCLC. Nat. Cancer 4, 629\u2013647 (2023).","journal-title":"Nat. Cancer"},{"key":"985_CR92","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1038\/s41586-025-08615-w","volume":"639","author":"K Goldberg","year":"2025","unstructured":"Goldberg, K. et al. Cell-autonomous innate immunity by proteasome-derived defence peptides. Nature 639, 1032\u20131041 (2025).","journal-title":"Nature"},{"key":"985_CR93","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1016\/j.molcel.2022.04.019","volume":"82","author":"J Vibert","year":"2022","unstructured":"Vibert, J. et al. Oncogenic chimeric transcription factors drive tumor-specific transcription, processing, and translation of silent genomic regions. Mol. Cell 82, 2458\u20132471.e9 (2022).","journal-title":"Mol. Cell"},{"key":"985_CR94","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1038\/nature08822","volume":"463","author":"R Beroukhim","year":"2010","unstructured":"Beroukhim, R. et al. The landscape of somatic copy-number alteration across human cancers. Nature 463, 899\u2013905 (2010).","journal-title":"Nature"},{"key":"985_CR95","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1089\/104454904322964760","volume":"23","author":"A Di Tommaso","year":"2004","unstructured":"Di Tommaso, A., Soler, C., Roos, C., Kitzis, A. & Ladeveze, V. The ink4a\/arf locus evolution in primates: characterization of three ARF sequences. DNA Cell Biol. 23, 167\u2013173 (2004).","journal-title":"DNA Cell Biol."},{"key":"985_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-53904-z","volume":"15","author":"E Gibbs","year":"2024","unstructured":"Gibbs, E. et al. p14 forms meso-scale assemblies upon phase separation with NPM1. Nat. Commun. 15, 9531 (2024).","journal-title":"Nat. Commun."},{"key":"985_CR97","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.jmb.2005.01.031","volume":"347","author":"C Qian","year":"2005","unstructured":"Qian, C. et al. Structure of the adaptor protein p14 reveals a profilin-like fold with distinct function. J. Mol. Biol. 347, 309\u2013321 (2005).","journal-title":"J. Mol. Biol."},{"key":"985_CR98","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/sj.onc.1207074","volume":"23","author":"NE Sharpless","year":"2004","unstructured":"Sharpless, N. E., Ramsey, M. R., Balasubramanian, P., Castrillon, D. H. & DePinho, R. A. The differential impact of p16INK4A\u00a0or p19ARF deficiency on cell growth and tumorigenesis. Oncogene 23, 379\u2013385 (2004).","journal-title":"Oncogene"},{"key":"985_CR99","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/35092592","volume":"413","author":"NE Sharpless","year":"2001","unstructured":"Sharpless, N. E. et al. Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis. Nature 413, 86\u201391 (2001).","journal-title":"Nature"},{"key":"985_CR100","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/S0092-8674(00)80452-3","volume":"91","author":"T Kamijo","year":"1997","unstructured":"Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 91, 649\u2013659 (1997).","journal-title":"Cell"},{"key":"985_CR101","doi-asserted-by":"publisher","first-page":"624752","DOI":"10.3389\/fonc.2020.624752","volume":"10","author":"Z Zhuang","year":"2020","unstructured":"Zhuang, Z. et al. Down-regulation of long non-coding RNA TINCR induces cell dedifferentiation and predicts progression in oral squamous cell carcinoma. Front. Oncol. 10, 624752 (2020).","journal-title":"Front. Oncol."},{"key":"985_CR102","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41586-025-08721-9","volume":"640","author":"E Fiorini","year":"2025","unstructured":"Fiorini, E. et al. MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC. Nature 640, 811\u2013820 (2025).","journal-title":"Nature"},{"key":"985_CR103","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1016\/j.cell.2025.12.009","volume":"189","author":"H Yi","year":"2026","unstructured":"Yi, H. et al. EcDNA-borne structural variants drive oncogenic fusion transcript amplification. Cell 189, 906\u2013921.e20 (2026).","journal-title":"Cell"},{"key":"985_CR104","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1101\/gad.353355.125","volume":"40","author":"A Tiwari","year":"2026","unstructured":"Tiwari, A. et al. Firefox, a protein encoded by circular PVT1, is essential for MYC-driven oncogenesis. Genes Dev. 40, 1688\u20131705 (2026).","journal-title":"Genes Dev."},{"key":"985_CR105","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003996","volume":"10","author":"Y Suenaga","year":"2014","unstructured":"Suenaga, Y. et al. NCYM, a cis-antisense gene of MYCN, encodes a de novo evolved protein that inhibits GSK3\u03b2 resulting in the stabilization of MYCN in human neuroblastomas. PLoS Genet. 10, e1003996 (2014).","journal-title":"PLoS Genet."},{"key":"985_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-4129-8","volume":"18","author":"EM O\u2019Brien","year":"2018","unstructured":"O\u2019Brien, E. M., Selfe, J. L., Martins, A. S., Walters, Z. S. & Shipley, J. M. The long non-coding RNA MYCNOS-01 regulates MYCN protein levels and affects growth of MYCN-amplified rhabdomyosarcoma and neuroblastoma cells. BMC Cancer 18, 217 (2018).","journal-title":"BMC Cancer"},{"key":"985_CR107","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1038\/onc.2015.422","volume":"35","author":"X Zhao","year":"2016","unstructured":"Zhao, X. et al. CTCF cooperates with noncoding RNA MYCNOS to promote neuroblastoma progression through facilitating MYCN expression. Oncogene 35, 3565\u20133576 (2016).","journal-title":"Oncogene"},{"key":"985_CR108","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1093\/jjco\/hyaa097","volume":"50","author":"Y Suenaga","year":"2020","unstructured":"Suenaga, Y., Nakatani, K. & Nakagawara, A. De novo evolved gene product NCYM in the pathogenesis and clinical outcome of human neuroblastomas and other cancers. Jpn. J. Clin. Oncol. 50, 839\u2013846 (2020).","journal-title":"Jpn. J. Clin. Oncol."},{"key":"985_CR109","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10717-9","volume":"11","author":"N Whiffin","year":"2020","unstructured":"Whiffin, N. et al. Characterising the loss-of-function impact of 5\u2032 untranslated region variants in 15,708 individuals. Nat. Commun. 11, 2523 (2020).","journal-title":"Nat. Commun."},{"key":"985_CR110","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/5082","volume":"21","author":"L Liu","year":"1999","unstructured":"Liu, L. et al. Mutation of the CDKN2A 5\u2032 UTR creates an aberrant initiation codon and predisposes to melanoma. Nat. Genet. 21, 128\u2013132 (1999).","journal-title":"Nat. Genet."},{"key":"985_CR111","doi-asserted-by":"publisher","first-page":"618","DOI":"10.3390\/biomedicines9060618","volume":"9","author":"L J\u00fcrgens","year":"2021","unstructured":"J\u00fcrgens, L. et al. Somatic functional deletions of upstream open reading frame-associated initiation and termination codons in human cancer. Biomedicines 9, 618 (2021).","journal-title":"Biomedicines"},{"key":"985_CR112","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1158\/1541-7786.MCR-21-0775","volume":"20","author":"A Nickless","year":"2022","unstructured":"Nickless, A. et al. Pan-cancer analysis reveals recurrent BCAR4 gene fusions across solid tumors. Mol. Cancer Res. 20, 1481\u20131488 (2022).","journal-title":"Mol. Cancer Res."},{"key":"985_CR113","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1126\/science.aad5214","volume":"351","author":"GV Kryukov","year":"2016","unstructured":"Kryukov, G. V. et al. MTAP deletion confers enhanced dependency on the PRMT5 arginine methyltransferase in cancer cells. Science 351, 1214\u20131218 (2016).","journal-title":"Science"},{"key":"985_CR114","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41586-020-1965-x","volume":"578","author":"E Rheinbay","year":"2020","unstructured":"Rheinbay, E. et al. Analyses of non-coding somatic drivers in 2,658 cancer whole genomes. Nature 578, 102\u2013111 (2020).","journal-title":"Nature"},{"key":"985_CR115","doi-asserted-by":"publisher","first-page":"eabg5601","DOI":"10.1126\/science.abg5601","volume":"376","author":"F Dietlein","year":"2022","unstructured":"Dietlein, F. et al. Genome-wide analysis of somatic noncoding mutation patterns in cancer. Science 376, eabg5601 (2022).","journal-title":"Science"},{"key":"985_CR116","doi-asserted-by":"publisher","first-page":"eaau5516","DOI":"10.1126\/scitranslmed.aau5516","volume":"10","author":"CM Laumont","year":"2018","unstructured":"Laumont, C. M. et al. Noncoding regions are the main source of targetable tumor-specific antigens. Sci. Transl. Med. 10, eaau5516 (2018).","journal-title":"Sci. Transl. Med."},{"key":"985_CR117","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10238","volume":"7","author":"CM Laumont","year":"2016","unstructured":"Laumont, C. M. et al. Global proteogenomic analysis of human MHC class I-associated peptides derived from non-canonical reading frames. Nat. Commun. 7, 10238 (2016).","journal-title":"Nat. Commun."},{"key":"985_CR118","doi-asserted-by":"publisher","first-page":"108815","DOI":"10.1016\/j.celrep.2021.108815","volume":"34","author":"MV Ruiz Cuevas","year":"2021","unstructured":"Ruiz Cuevas, M. V. et al. Most non-canonical proteins uniquely populate the proteome or immunopeptidome. Cell Rep. 34, 108815 (2021).","journal-title":"Cell Rep."},{"key":"985_CR119","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1038\/s41586-023-05771-9","volume":"616","author":"KW Ng","year":"2023","unstructured":"Ng, K. W. et al. Antibodies against endogenous retroviruses promote lung cancer immunotherapy. Nature 616, 563\u2013573 (2023).","journal-title":"Nature"},{"key":"985_CR120","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/nature21036","volume":"541","author":"A Sendoel","year":"2017","unstructured":"Sendoel, A. et al. Translation from unconventional 5\u2032 start sites drives tumour initiation. Nature 541, 494\u2013499 (2017).","journal-title":"Nature"},{"key":"985_CR121","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1084\/jem.20181726","volume":"216","author":"K Singh","year":"2019","unstructured":"Singh, K. et al. c-MYC regulates mRNA translation efficiency and start-site selection in lymphoma. J. Exp. Med. 216, 1509\u20131524 (2019).","journal-title":"J. Exp. Med."},{"key":"985_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28705-x","volume":"13","author":"LK Smith","year":"2022","unstructured":"Smith, L. K. et al. Adaptive translational reprogramming of metabolism limits the response to targeted therapy in BRAF melanoma. Nat. Commun. 13, 1100 (2022).","journal-title":"Nat. Commun."},{"key":"985_CR123","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1016\/j.molcel.2023.06.012","volume":"83","author":"O Oksuz","year":"2023","unstructured":"Oksuz, O. et al. Transcription factors interact with RNA to regulate genes. Mol. Cell 83, 2449\u20132463.e13 (2023).","journal-title":"Mol. Cell"},{"key":"985_CR124","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2321305121","volume":"121","author":"B Valcikova","year":"2024","unstructured":"Valcikova, B. et al. eIF4F controls ERK MAPK signaling in melanomas with and mutations. Proc. Natl Acad. Sci. USA 121, e2321305121 (2024).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"985_CR125","doi-asserted-by":"publisher","first-page":"5326","DOI":"10.1158\/0008-5472.CAN-07-5876","volume":"68","author":"C-J Lin","year":"2008","unstructured":"Lin, C.-J., Cencic, R., Mills, J. R., Robert, F. & Pelletier, J. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Cancer Res. 68, 5326\u20135334 (2008).","journal-title":"Cancer Res."},{"key":"985_CR126","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.60151","volume":"9","author":"H Ruan","year":"2020","unstructured":"Ruan, H. et al. eIF4E S209 phosphorylation licenses myc- and stress-driven oncogenesis. eLife 9, e60151 (2020).","journal-title":"eLife"},{"key":"985_CR127","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1126\/science.adh7950","volume":"384","author":"NJ Boon","year":"2024","unstructured":"Boon, N. J. et al. DNA damage induces p53-independent apoptosis through ribosome stalling. Science 384, 785\u2013792 (2024).","journal-title":"Science"},{"key":"985_CR128","doi-asserted-by":"publisher","first-page":"1904","DOI":"10.1016\/j.molcel.2024.04.012","volume":"84","author":"C Yang","year":"2024","unstructured":"Yang, C. et al. Arginine deprivation enriches lung cancer proteomes with cysteine by inducing arginine-to-cysteine substitutants. Mol. Cell 84, 1904\u20131916.e7 (2024).","journal-title":"Mol. Cell"},{"key":"985_CR129","doi-asserted-by":"publisher","first-page":"4709","DOI":"10.1016\/j.molcel.2021.09.002","volume":"81","author":"J Champagne","year":"2021","unstructured":"Champagne, J. et al. Oncogene-dependent sloppiness in mRNA translation. Mol. Cell 81, 4709\u20134721.e9 (2021).","journal-title":"Mol. Cell"},{"key":"985_CR130","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.tig.2022.05.009","volume":"38","author":"J Champagne","year":"2022","unstructured":"Champagne, J., Mordente, K., Nagel, R. & Agami, R. Slippy-sloppy translation: a tale of programmed and induced-ribosomal frameshifting. Trends Genet. 38, 1123\u20131133 (2022).","journal-title":"Trends Genet."},{"key":"985_CR131","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1016\/j.trecan.2024.09.011","volume":"10","author":"H Urra","year":"2024","unstructured":"Urra, H., Aravena, R., Gonz\u00e1lez-Johnson, L. & Hetz, C. The UPRising connection between endoplasmic reticulum stress and the tumor microenvironment. Trends Cancer 10, 1161\u20131173 (2024).","journal-title":"Trends Cancer"},{"key":"985_CR132","doi-asserted-by":"publisher","first-page":"aad3867","DOI":"10.1126\/science.aad3867","volume":"351","author":"SR Starck","year":"2016","unstructured":"Starck, S. R. et al. Translation from the 5\u2032 untranslated region shapes the integrated stress response. Science 351, aad3867 (2016).","journal-title":"Science"},{"key":"985_CR133","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12816-z","volume":"10","author":"Q Chu","year":"2019","unstructured":"Chu, Q. et al. Regulation of the ER stress response by a mitochondrial microprotein. Nat. Commun. 10, 4883 (2019).","journal-title":"Nat. Commun."},{"key":"985_CR134","doi-asserted-by":"publisher","first-page":"gkaf1072","DOI":"10.1093\/nar\/gkaf1072","volume":"53","author":"L Lafranchi","year":"2025","unstructured":"Lafranchi, L. et al. Pooled overexpression screening identifies PIPPI as a novel microprotein involved in the ER stress response. Nucleic Acids Res. 53, gkaf1072 (2025).","journal-title":"Nucleic Acids Res."},{"key":"985_CR135","doi-asserted-by":"publisher","first-page":"4907","DOI":"10.1182\/blood-2005-08-3531","volume":"107","author":"EA Obeng","year":"2006","unstructured":"Obeng, E. A. et al. Proteasome inhibitors induce a terminal unfolded protein response in multiple myeloma cells. Blood 107, 4907\u20134916 (2006).","journal-title":"Blood"},{"key":"985_CR136","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.3390\/ijms22041526","volume":"22","author":"J Qu","year":"2021","unstructured":"Qu, J., Zou, T. & Lin, Z. The roles of the ubiquitin-proteasome system in the endoplasmic reticulum stress pathway. Int. J. Mol. Sci. 22, 1526 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"985_CR137","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00401-025-02947-7","volume":"150","author":"ZM Augur","year":"2025","unstructured":"Augur, Z. M. et al. Genetic and proteomic analysis identifies BAG3 as an amyloid-responsive regulator of neuronal proteostasis. Acta Neuropathol. 150, 43 (2025).","journal-title":"Acta Neuropathol."},{"key":"985_CR138","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41586-023-05946-4","volume":"617","author":"JS Kesner","year":"2023","unstructured":"Kesner, J. S. et al. Noncoding translation mitigation. Nature 617, 395\u2013402 (2023).","journal-title":"Nature"},{"key":"985_CR139","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.tcb.2024.09.004","volume":"35","author":"JS Kesner","year":"2025","unstructured":"Kesner, J. S. & Wu, X. Mechanisms suppressing noncoding translation. Trends Cell Biol. 35, 627\u2013635 (2025).","journal-title":"Trends Cell Biol."},{"key":"985_CR140","doi-asserted-by":"publisher","first-page":"104273","DOI":"10.1016\/j.isci.2022.104273","volume":"25","author":"YAT Kasu","year":"2022","unstructured":"Kasu, Y. A. T. et al. BAG6 prevents the aggregation of neurodegeneration-associated fragments of TDP43. iScience 25, 104273 (2022).","journal-title":"iScience"},{"key":"985_CR141","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1038\/s41423-024-01195-1","volume":"21","author":"B Alashkar Alhamwe","year":"2024","unstructured":"Alashkar Alhamwe, B. et al. BAG6 restricts pancreatic cancer progression by suppressing the release of IL33-presenting extracellular vesicles and the activation of mast cells. Cell. Mol. Immunol. 21, 918\u2013931 (2024).","journal-title":"Cell. Mol. Immunol."},{"key":"985_CR142","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1038\/s41587-020-00806-2","volume":"39","author":"JR Prensner","year":"2021","unstructured":"Prensner, J. R. et al. Noncanonical open reading frames encode functional proteins essential for cancer cell survival. Nat. Biotechnol. 39, 697\u2013704 (2021).","journal-title":"Nat. Biotechnol."},{"key":"985_CR143","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.aay0262","volume":"367","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Pervasive functional translation of noncanonical human open reading frames. Science 367, 1140\u20131146 (2020).","journal-title":"Science"},{"key":"985_CR144","doi-asserted-by":"publisher","DOI":"10.1172\/JCI159940","volume":"133","author":"C Zheng","year":"2023","unstructured":"Zheng, C. et al. CRISPR\/Cas9 screen uncovers functional translation of cryptic lncRNA-encoded open reading frames in human cancer. J. Clin. Invest. 133, e159940 (2023).","journal-title":"J. Clin. Invest."},{"key":"985_CR145","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1016\/j.molcel.2022.06.035","volume":"82","author":"Z Na","year":"2022","unstructured":"Na, Z. et al. Mapping subcellular localizations of unannotated microproteins and alternative proteins with MicroID. Mol. Cell 82, 2900\u20132911.e7 (2022).","journal-title":"Mol. Cell"},{"key":"985_CR146","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.19760","volume":"5","author":"MA Horlbeck","year":"2016","unstructured":"Horlbeck, M. A. et al. Compact and highly active next-generation libraries for CRISPR-mediated gene repression and activation. eLife 5, e19760 (2016).","journal-title":"eLife"},{"key":"985_CR147","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1126\/science.aac7557","volume":"350","author":"VA Blomen","year":"2015","unstructured":"Blomen, V. A. et al. Gene essentiality and synthetic lethality in haploid human cells. Science 350, 1092\u20131096 (2015).","journal-title":"Science"},{"key":"985_CR148","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1016\/j.cell.2015.11.015","volume":"163","author":"T Hart","year":"2015","unstructured":"Hart, T. et al. High-resolution CRISPR screens reveal fitness genes and genotype-specific cancer liabilities. Cell 163, 1515\u20131526 (2015).","journal-title":"Cell"},{"key":"985_CR149","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1126\/science.aac7041","volume":"350","author":"T Wang","year":"2015","unstructured":"Wang, T. et al. Identification and characterization of essential genes in the human genome. Science 350, 1096\u20131101 (2015).","journal-title":"Science"},{"key":"985_CR150","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.ccell.2023.12.016","volume":"42","author":"C Pacini","year":"2024","unstructured":"Pacini, C. et al. A comprehensive clinically informed map of dependencies in cancer cells and framework for target prioritization. Cancer Cell 42, 301\u2013316.e9 (2024).","journal-title":"Cancer Cell"},{"key":"985_CR151","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.cell.2017.06.010","volume":"170","author":"A Tsherniak","year":"2017","unstructured":"Tsherniak, A. et al. Defining a cancer dependency map. Cell 170, 564\u2013576.e16 (2017).","journal-title":"Cell"},{"key":"985_CR152","doi-asserted-by":"publisher","first-page":"100099","DOI":"10.1016\/j.xgen.2022.100099","volume":"2","author":"TY Park","year":"2022","unstructured":"Park, T. Y., Leiserson, M. D. M., Klau, G. W. & Raphael, B. J. SuperDendrix algorithm integrates genetic dependencies and genomic alterations across pathways and cancer types. Cell Genom. 2, 100099 (2022).","journal-title":"Cell Genom."},{"key":"985_CR153","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1016\/j.cell.2025.01.046","volume":"188","author":"Q Jiang","year":"2025","unstructured":"Jiang, Q. et al. HIF regulates multiple translated endogenous retroviruses: implications for cancer immunotherapy. Cell 188, 1807\u20131827.e34 (2025).","journal-title":"Cell"},{"key":"985_CR154","doi-asserted-by":"publisher","first-page":"100737","DOI":"10.1016\/j.omto.2023.100737","volume":"31","author":"L Zeng","year":"2023","unstructured":"Zeng, L. et al. An epitope encoded by uORF of RNF10 elicits a therapeutic anti-tumor immune response. Mol. Ther. Oncolytics 31, 100737 (2023).","journal-title":"Mol. Ther. Oncolytics"},{"key":"985_CR155","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1038\/s43018-025-00979-2","volume":"6","author":"A Apavaloaei","year":"2025","unstructured":"Apavaloaei, A. et al. Tumor antigens preferentially derive from unmutated genomic sequences in melanoma and non-small cell lung cancer. Nat. Cancer 6, 1419\u20131437 (2025).","journal-title":"Nat. Cancer"},{"key":"985_CR156","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-023-06834-7","volume":"625","author":"D Huang","year":"2024","unstructured":"Huang, D. et al. Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides. Nature 625, 593\u2013602 (2024).","journal-title":"Nature"},{"key":"985_CR157","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/j.immuni.2024.12.004","volume":"58","author":"J Champagne","year":"2025","unstructured":"Champagne, J. et al. Adoptive T cell therapy targeting an inducible and broadly shared product of aberrant mRNA translation. Immunity 58, 247\u2013262.e9 (2025).","journal-title":"Immunity"},{"key":"985_CR158","doi-asserted-by":"publisher","first-page":"eadn3628","DOI":"10.1126\/sciadv.adn3628","volume":"10","author":"ME Camarena","year":"2024","unstructured":"Camarena, M. E. et al. Microproteins encoded by noncanonical ORFs are a major source of tumor-specific antigens in a liver cancer patient meta-cohort. Sci. Adv. 10, eadn3628 (2024).","journal-title":"Sci. Adv."},{"key":"985_CR159","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-026-03003-9","author":"K Manakongtreecheep","year":"2026","unstructured":"Manakongtreecheep, K. et al. Sensitive detection of cancer antigens enabled by user-defined peptide libraries. Nat. Biotechnol. https:\/\/doi.org\/10.1038\/s41587-026-03003-9 (2026).","journal-title":"Nat. Biotechnol."},{"key":"985_CR160","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/study\/nct06530082 (2024)."},{"key":"985_CR161","doi-asserted-by":"publisher","first-page":"4052","DOI":"10.1158\/1538-7445.AM2026-4052","volume":"86","author":"T Cornforth","year":"2026","unstructured":"Cornforth, T. et al. Abstract 4052: ENA101: a first-in-class bispecific T cell engager targeting a DARKFOX peptide presented by solid tumors. Cancer Res. 86, 4052\u20134052 (2026).","journal-title":"Cancer Res."},{"key":"985_CR162","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-002071","volume":"9","author":"A Marcu","year":"2021","unstructured":"Marcu, A. et al. HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy. J. Immunother. Cancer 9, e002071 (2021).","journal-title":"J. Immunother. Cancer"},{"key":"985_CR163","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2025-012083","volume":"13","author":"L Bichmann","year":"2025","unstructured":"Bichmann, L. et al. HLA Ligand Atlas DIA: extending the benign immunopeptidomics resource with increased sensitivity through data-independent acquisition mass spectrometry. J. Immunother. Cancer 13, e012083 (2025).","journal-title":"J. Immunother. Cancer"},{"key":"985_CR164","doi-asserted-by":"publisher","first-page":"D436","DOI":"10.1093\/nar\/gkae1092","volume":"53","author":"R Vita","year":"2025","unstructured":"Vita, R. et al. The Immune Epitope Database (IEDB): 2024 update. Nucleic Acids Res. 53, D436\u2013D443 (2025).","journal-title":"Nucleic Acids Res."},{"key":"985_CR165","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1038\/s41571-019-0184-6","volume":"16","author":"NN Shah","year":"2019","unstructured":"Shah, N. N. & Fry, T. J. Mechanisms of resistance to CAR T cell therapy. Nat. Rev. Clin. Oncol. 16, 372\u2013385 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"985_CR166","doi-asserted-by":"publisher","first-page":"2664","DOI":"10.3389\/fimmu.2019.02664","volume":"10","author":"X Xu","year":"2019","unstructured":"Xu, X. et al. Mechanisms of relapse after CD19 CAR T-cell therapy for acute lymphoblastic leukemia and its prevention and treatment strategies. Front. Immunol. 10, 2664 (2019).","journal-title":"Front. Immunol."},{"key":"985_CR167","doi-asserted-by":"publisher","first-page":"4634","DOI":"10.1016\/j.cell.2022.10.017","volume":"185","author":"L Funk","year":"2022","unstructured":"Funk, L. et al. The phenotypic landscape of essential human genes. Cell 185, 4634\u20134653.e22 (2022).","journal-title":"Cell"},{"key":"985_CR168","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/dom.13378","volume":"20","author":"M Liu","year":"2018","unstructured":"Liu, M. et al. Biosynthesis, structure, and folding of the insulin precursor protein. Diabetes Obes. Metab. 20, 28\u201350 (2018).","journal-title":"Diabetes Obes. Metab."},{"key":"985_CR169","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.chembiol.2025.10.002","volume":"32","author":"M Zhang","year":"2025","unstructured":"Zhang, M., Chen, M., Li, P. & Min, J. Therapeutic targeting of WDR5-MLL1 by EMBOW-derived peptides suppresses leukemia progression. Cell Chem. Biol. 32, 1353\u20131366.e6 (2025).","journal-title":"Cell Chem. Biol."},{"key":"985_CR170","doi-asserted-by":"publisher","first-page":"eaar5012","DOI":"10.1126\/scitranslmed.aar5012","volume":"11","author":"M-E Beaulieu","year":"2019","unstructured":"Beaulieu, M.-E. et al. Intrinsic cell-penetrating activity propels omomyc from proof of concept to viable anti-MYC therapy. Sci. Transl. Med. 11, eaar5012 (2019).","journal-title":"Sci. Transl. Med."},{"key":"985_CR171","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/s41591-024-02805-1","volume":"30","author":"E Garralda","year":"2024","unstructured":"Garralda, E. et al. MYC targeting by OMO-103 in solid tumors: a phase 1 trial. Nat. Med. 30, 762\u2013771 (2024).","journal-title":"Nat. Med."},{"key":"985_CR172","doi-asserted-by":"publisher","DOI":"10.1002\/anie.202416082","volume":"64","author":"BD Ellenbroek","year":"2025","unstructured":"Ellenbroek, B. D. et al. Development of DuoMYC: a synthetic cell penetrant miniprotein that efficiently inhibits the oncogenic transcription factor MYC. Angew. Chem. Int. Ed. 64, e202416082 (2025).","journal-title":"Angew. Chem. Int. Ed."},{"key":"985_CR173","doi-asserted-by":"publisher","DOI":"10.1038\/srep22298","volume":"6","author":"C Yu","year":"2016","unstructured":"Yu, C. et al. Structure-based inhibitor design for the intrinsically disordered protein c-Myc. Sci. Rep. 6, 22298 (2016).","journal-title":"Sci. Rep."},{"key":"985_CR174","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41586-025-09248-9","volume":"644","author":"C Liu","year":"2025","unstructured":"Liu, C. et al. Diffusing protein binders to intrinsically disordered proteins. Nature 644, 809\u2013817 (2025).","journal-title":"Nature"},{"key":"985_CR175","doi-asserted-by":"publisher","first-page":"eadr8063","DOI":"10.1126\/science.adr8063","volume":"389","author":"K Wu","year":"2025","unstructured":"Wu, K. et al. Design of intrinsically disordered region binding proteins. Science 389, eadr8063 (2025).","journal-title":"Science"},{"key":"985_CR176","doi-asserted-by":"publisher","first-page":"108797","DOI":"10.1016\/j.pharmthera.2025.108797","volume":"267","author":"J Fantini","year":"2025","unstructured":"Fantini, J. et al. Conformationally adaptive therapeutic peptides for diseases caused by intrinsically disordered proteins (IDPs). New paradigm for drug discovery: target the target, not the arrow. Pharmacol. Ther. 267, 108797 (2025).","journal-title":"Pharmacol. Ther."},{"key":"985_CR177","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1038\/s41586-023-06228-9","volume":"618","author":"H Ozadam","year":"2023","unstructured":"Ozadam, H. et al. Single-cell quantification of ribosome occupancy in early mouse development. Nature 618, 1057\u20131064 (2023).","journal-title":"Nature"},{"key":"985_CR178","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/s41586-021-03887-4","volume":"597","author":"M VanInsberghe","year":"2021","unstructured":"VanInsberghe, M., van den Berg, J., Andersson-Rolf, A., Clevers, H. & van Oudenaarden, A. Single-cell Ribo-seq reveals cell cycle-dependent translational pausing. Nature 597, 561\u2013565 (2021).","journal-title":"Nature"},{"key":"985_CR179","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1038\/s41596-025-01248-3","volume":"21","author":"J Ren","year":"2026","unstructured":"Ren, J. et al. Spatially resolved in situ profiling of mRNA life cycle at transcriptome scale in intact cells and tissues using STARmap PLUS, RIBOmap and TEMPOmap. Nat. Protoc. 21, 1629\u20131661 (2026).","journal-title":"Nat. Protoc."},{"key":"985_CR180","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.1038\/s41592-025-02867-0","volume":"22","author":"X Sui","year":"2025","unstructured":"Sui, X. et al. Scalable spatial single-cell transcriptomics and translatomics in 3D thick tissue blocks. Nat. Methods 22, 2574\u20132584 (2025).","journal-title":"Nat. Methods"},{"key":"985_CR181","doi-asserted-by":"publisher","first-page":"eadd3067","DOI":"10.1126\/science.add3067","volume":"380","author":"H Zeng","year":"2023","unstructured":"Zeng, H. et al. Spatially resolved single-cell translatomics at molecular resolution. Science 380, eadd3067 (2023).","journal-title":"Science"},{"key":"985_CR182","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1016\/j.cell.2024.02.045","volume":"187","author":"EM Unterauer","year":"2024","unstructured":"Unterauer, E. M. et al. Spatial proteomics in neurons at single-protein resolution. Cell 187, 1785\u20131800.e16 (2024).","journal-title":"Cell"},{"key":"985_CR183","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/s41593-022-01164-9","volume":"25","author":"EE Duffy","year":"2022","unstructured":"Duffy, E. E. et al. Developmental dynamics of RNA translation in the human brain. Nat. Neurosci. 25, 1353\u20131365 (2022).","journal-title":"Nat. Neurosci."},{"key":"985_CR184","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/s41589-019-0425-0","volume":"16","author":"TF Martinez","year":"2020","unstructured":"Martinez, T. F. et al. Accurate annotation of human protein-coding small open reading frames. Nat. Chem. Biol. 16, 458\u2013468 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"985_CR185","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.91078","volume":"2","author":"N Desai","year":"2017","unstructured":"Desai, N. et al. Diverse repetitive element RNA expression defines epigenetic and immunologic features of colon cancer. JCI Insight 2, e91078 (2017).","journal-title":"JCI Insight"},{"key":"985_CR186","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42417-w","volume":"14","author":"A Goyal","year":"2023","unstructured":"Goyal, A. et al. DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts. Nat. Commun. 14, 6731 (2023).","journal-title":"Nat. Commun."},{"key":"985_CR187","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/j.cell.2019.07.016","volume":"178","author":"H Sberro","year":"2019","unstructured":"Sberro, H. et al. Large-scale analyses of human microbiomes reveal thousands of small, novel genes. Cell 178, 1245\u20131259.e14 (2019).","journal-title":"Cell"},{"key":"985_CR188","doi-asserted-by":"publisher","first-page":"3761","DOI":"10.1016\/j.cell.2024.05.013","volume":"187","author":"CD Santos-J\u00fanior","year":"2024","unstructured":"Santos-J\u00fanior, C. D. et al. Discovery of antimicrobial peptides in the global microbiome with machine learning. Cell 187, 3761\u20133778.e16 (2024).","journal-title":"Cell"},{"key":"985_CR189","doi-asserted-by":"publisher","DOI":"10.1128\/msystems.01178-22","volume":"8","author":"M Maranga","year":"2023","unstructured":"Maranga, M. et al. Comprehensive functional annotation of metagenomes and microbial genomes using a deep learning-based method. mSystems 8, e0117822 (2023).","journal-title":"mSystems"},{"key":"985_CR190","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01544-x","volume":"8","author":"M Kleiner","year":"2017","unstructured":"Kleiner, M. et al. Assessing species biomass contributions in microbial communities via metaproteomics. Nat. Commun. 8, 1558 (2017).","journal-title":"Nat. Commun."},{"key":"985_CR191","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.1016\/j.cell.2024.07.027","volume":"187","author":"MDT Torres","year":"2024","unstructured":"Torres, M. D. T. et al. Mining human microbiomes reveals an untapped source of peptide antibiotics. Cell 187, 5453\u20135467.e15 (2024).","journal-title":"Cell"},{"key":"985_CR192","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.tibtech.2024.09.008","volume":"43","author":"MDT Torres","year":"2025","unstructured":"Torres, M. D. T., Cesaro, A. & de la Fuente-Nunez, C. Peptides from non-immune proteins target infections through antimicrobial and immunomodulatory properties. Trends Biotechnol. 43, 184\u2013205 (2025).","journal-title":"Trends Biotechnol."},{"key":"985_CR193","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.tig.2024.12.004","volume":"41","author":"B Galeota-Sprung","year":"2025","unstructured":"Galeota-Sprung, B., Bhatt, A. S. & de la Fuente-Nunez, C. Microproteins: emerging roles as antibiotics. Trends Genet. 41, 104\u2013106 (2025).","journal-title":"Trends Genet."},{"key":"985_CR194","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.cell.2018.12.021","volume":"176","author":"JN Vo","year":"2019","unstructured":"Vo, J. N. et al. The landscape of circular RNA in cancer. Cell 176, 869\u2013881.e13 (2019).","journal-title":"Cell"},{"key":"985_CR195","doi-asserted-by":"publisher","first-page":"21170","DOI":"10.1074\/jbc.R117.807560","volume":"292","author":"N Vigneron","year":"2017","unstructured":"Vigneron, N., Ferrari, V., Stroobant, V., Abi Habib, J. & Van den Eynde, B. J. Peptide splicing by the proteasome. J. Biol. Chem. 292, 21170\u201321179 (2017).","journal-title":"J. Biol. Chem."},{"key":"985_CR196","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.4049\/jimmunol.1402455","volume":"195","author":"CR Berkers","year":"2015","unstructured":"Berkers, C. R. et al. Definition of proteasomal peptide splicing rules for high-efficiency spliced peptide presentation by MHC class I molecules. J. Immunol. 195, 4085\u20134095 (2015).","journal-title":"J. Immunol."},{"key":"985_CR197","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45339-3","volume":"15","author":"WT Soh","year":"2024","unstructured":"Soh, W. T. et al. Protein degradation by human 20S proteasomes elucidates the interplay between peptide hydrolysis and splicing. Nat. Commun. 15, 1147 (2024).","journal-title":"Nat. Commun."},{"key":"985_CR198","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.4049\/jimmunol.1402454","volume":"195","author":"CR Berkers","year":"2015","unstructured":"Berkers, C. R. et al. Peptide splicing in the proteasome creates a novel type of antigen with an isopeptide linkage. J. Immunol. 195, 4075\u20134084 (2015).","journal-title":"J. Immunol."},{"key":"985_CR199","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.1074\/mcp.RA118.000877","volume":"17","author":"R Mylonas","year":"2018","unstructured":"Mylonas, R. et al. Estimating the contribution of proteasomal spliced peptides to the HLA-I ligandome. Mol. Cell. Proteom. 17, 2347\u20132357 (2018).","journal-title":"Mol. Cell. Proteom."},{"key":"985_CR200","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1101\/gr.259200.119","volume":"30","author":"CD Treiber","year":"2020","unstructured":"Treiber, C. D. & Waddell, S. Transposon expression in the Drosophila brain is driven by neighboring genes and diversifies the neural transcriptome. Genome Res. 30, 1559\u20131569 (2020).","journal-title":"Genome Res."},{"key":"985_CR201","doi-asserted-by":"publisher","first-page":"9764","DOI":"10.1093\/nar\/gkad671","volume":"51","author":"DS Oliveira","year":"2023","unstructured":"Oliveira, D. S. et al. ChimeraTE: a pipeline to detect chimeric transcripts derived from genes and transposable elements. Nucleic Acids Res. 51, 9764\u20139784 (2023).","journal-title":"Nucleic Acids Res."},{"key":"985_CR202","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-35595-6","volume":"13","author":"AD Fedorova","year":"2022","unstructured":"Fedorova, A. D., Kiniry, S. J., Andreev, D. E., Mudge, J. M. & Baranov, P. V. Thousands of human non-AUG extended proteoforms lack evidence of evolutionary selection among mammals. Nat. Commun. 13, 7910 (2022).","journal-title":"Nat. Commun."},{"key":"985_CR203","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.tig.2024.12.001","volume":"41","author":"S Azam","year":"2025","unstructured":"Azam, S., Yang, F. & Wu, X. Finding functional microproteins. Trends Genet. 41, 107\u2013118 (2025).","journal-title":"Trends Genet."}],"container-title":["Nature Reviews Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00985-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00985-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00985-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T17:01:19Z","timestamp":1791478879000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41568-026-00985-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":203,"alternative-id":["985"],"URL":"https:\/\/doi.org\/10.1038\/s41568-026-00985-1","relation":{},"ISSN":["1474-175X","1474-1768"],"issn-type":[{"value":"1474-175X","type":"print"},{"value":"1474-1768","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"7 September 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.R.P. is a member of the scientific advisory board for, and receives financial research support from, ProFound Therapeutics and has received honoraria from Regeneron Pharmaceuticals. W.A.F-P. is a cofounder of and serves on the scientific advisory board of Novello Therapeutics; has consulted for Longitude Capital and Third Rock Ventures; holds equity in Regeneron, CRISPR Therapeutics and Novello Therapeutics; and receives research support from Arcus Biosciences, Pyxis Oncology, Dragonfly Therapeutics, Philogen, Amgen and AstraZeneca. J.G.A. is a paid consultant for Moderna. C.J.W. holds equity in BioNTech and is a member of the scientific advisory boards of Repertoire, Aethon Therapeutics, Nature\u2019s Toolbox and Adventris. J.S.W. declares outside interest in 5AM Ventures, Amgen, nChroma Bio, DEM Biosciences, KSQ Therapeutics, Maze Therapeutics, Tenaya Therapeutics, Tessera Therapeutics, Thermo Fisher Scientific, Third Rock Ventures and Xaira Therapeutics. T.N.S. declares advisory roles for Allogene Therapeutics, Asher Bio, AstraZeneca, JNJ and Scenic Biotech; is a stockholder in Allogene Therapeutics, Asher Therapeutics, Cell Control, Polar Therapeutics and Scenic Biotech; and is a venture partner at Third Rock Ventures, all outside the current work. Y.M. is an equity holder, scientific co-founder and consultant of Promise Bio, an equity holder and consultant for Biolight\/Modifeye Biosciences and a member of the scientific advisory board of Erisyon. Y.P., S.v.H. and R.A. declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}